RadNet (RDNT) Stock Forecast & Price Target

$72.70 +1.32 (+1.85%)

(As of 12/20/2024 05:31 PM ET)

RadNet - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 5 Analyst Ratings

Sell
0

Hold
0

Buy
5

Based on 5 Wall Street analysts who have issued ratings for RadNet in the last 12 months, the stock has a consensus rating of "Buy." Out of the 5 analysts, 4 have given a buy rating, and 1 has given a strong buy rating for RDNT.

Consensus Price Target

$84.75
16.57% Upside

According to the 5 analysts' twelve-month price targets for RadNet, the average price target is $84.75. The highest price target for RDNT is $100.00, while the lowest price target for RDNT is $60.00. The average price target represents a forecasted upside of 16.57% from the current price of $72.70.

Get the Latest News and Ratings for RDNT and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for RadNet and its competitors.

RDNT Analyst Ratings Over Time

Type	Current Forecast 12/22/23 to 12/21/24	1 Month Ago 11/22/23 to 11/21/24	3 Months Ago 9/23/23 to 9/22/24	1 Year Ago 12/22/22 to 12/22/23
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	4 Buy rating(s)	4 Buy rating(s)	3 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$84.75	$74.75	$72.25	$34.00
Forecasted Upside	16.57% Upside	-8.43% Downside	4.20% Upside	-3.41% Downside
Consensus Rating	Buy	Buy	Buy	Buy

Your chance to get on the next “60-Second Trade” (Ad)

Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!

Just head over here!

RDNT Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

RDNT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

RadNet Stock vs. The Competition

Type	RadNet	Medical Companies	S&P 500
Consensus Rating Score	3.20	2.81	2.51
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	16.57% Upside	25,828.59% Upside	14.54% Upside
News Sentiment Rating	Very Positive News See Recent RDNT News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/5/2024	Jefferies Financial Group 2 of 5 stars		Boost Target	Buy ➝ Buy	$82.00 ➝ $100.00	+27.80%
12/4/2024	Barclays 3 of 5 stars	A. Mok Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$79.00 ➝ $85.00	+5.41%
11/29/2024	Truist Financial 2 of 5 stars		Boost Target	Buy ➝ Buy	$80.00 ➝ $94.00	+14.97%
10/4/2024	Sidoti Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Ramgopal Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
5/10/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$50.00 ➝ $60.00	+9.13%
3/31/2023	CJS Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$30.00	+22.55%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 10:56 PM ET.

RDNT Forecast - Frequently Asked Questions

: According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for RadNet is $84.75, with a high forecast of $100.00 and a low forecast of $60.00.
: 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RadNet in the last year. There are currently 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" RDNT shares.
: According to analysts, RadNet's stock has a predicted upside of 16.57% based on their 12-month stock forecasts.
: Over the previous 90 days, RadNet's stock had 1 upgrade by analysts.
: RadNet has been rated by research analysts at Barclays, Jefferies Financial Group, Sidoti, and Truist Financial in the past 90 days.
: Analysts like RadNet more than other "medical" companies. The consensus rating for RadNet is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how RDNT compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Your chance to get on the next “60-Second Trade” (Ad)

Just head over here!

This page (NASDAQ:RDNT) was last updated on 12/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

RadNet (RDNT) Stock Forecast & Price Target